Acutaas Chemicals President Ashish Kumar Pandey appointed
Acutaas Chemicals (BSE: ACUTAAS) said Ashish Kumar Pandey, President, has been appointed; and Uday Desai has been appointed. The company is valued at about ₹31,869 crore.
What happened
Acutaas Chemicals (BSE: ACUTAAS) informed the stock exchanges on 2 November 2026 at 05:50 PM that Ashish Kumar Pandey, President, has been appointed; and Uday Desai has been appointed.
From the filing: "Ashish Kumar Pandey has been appointed as Assistant Vice President — Operations (Cluster Head — Unit 2 & 3) designated as Senior Management Personnel of the Company, with effect from November 2, 2026. 2."
Company snapshot
Acutaas Chemicals is a mid-cap company in the Healthcare sector, with a market value of about ₹31,869 crore.
The stock last traded at ₹3,892.6, against a 52-week range of ₹1,570–₹4,032.2 (3.5% below the high).
Before this filing the shares had moved +22.1% over the month and +28.5% over three months. Average daily turnover over the last 20 sessions was about ₹305 crore.
Promoters held 32.66% at the end of Q2 FY27. Foreign institutions owned 22.62% and domestic institutions 19.40%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 306 | 72.2 | 8.82 |
| Q3 FY26 | 393 | 108 | 13.19 |
| Q4 FY26 | 433 | 131.8 | 16.09 |
| Q1 FY27 | 330 | 74.3 | 9.07 |
| Q2 FY27 | 437 | 125.2 | 15.29 |
What history shows
This is not the company's first management change disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 1.9% on average the next trading day and was down 6.2% on average after five days (2 filings with price data).
Across 112 similar disclosures by other Healthcare companies, shares moved +1.0% on average the next day and +1.7% over five days; 49% of them rose the next day.
Market-wide, 4,084 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 26 Sept 2026 | Management change | +1.0% | −4.6% |
| 2 Jul 2026 | Management change | −4.8% | −7.9% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
In the news
Recent coverage elsewhere (links open the original publisher):
- Acutaas Chemicals rallies 13 per cent to record high after strong Q2
- Acutaas Chemicals rallies 13%; hits record high on strong Q2 results
- Why Acutaas Chemicals Share Price is Rising
- Acutaas Chemicals Q2 Results: Net Profit Jumps 73% YoY To Rs 125 Crore, Stock Hits All-Time High
- Acutaas Chemicals Sept-Quarter Consol Net Profit 1.25 Billion Rupees
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.